Tsoyi and other researchers found that PTPRJ is downregulated in clinical cases of Idiopathic Pulmonary Fibrosis (IPF) and that PTPRJ downregulation modulates the profibrotic response. The gene discussed is PTPRJ; the disease is pulmonary fibrosis.